Chemotherapy Drugs Current Events | Chemotherapy Drugs News | 4
|
| Page
4 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
Discovery offers potential new pancreatic cancer treatment
Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed... view more... (2009-11-03)
Phase II study shows combination improves survival of metastatic melanoma patients
Two chemotherapy drugs combined with an agent that prevents the growth of blood vessels significantly delayed the spread of tumors in patients with metastatic melanoma. view more (2007-06-04)
Gene thought to assist chemo may help cancer thrive
A gene thought to be essential in helping chemotherapy kill cancer cells, may actually help them thrive. view more (2007-05-16)
Chemotherapy with bevacizumab increases risk of blood clots in arteries
Treatment with chemotherapy and bevacizumab, an anticancer drug, is associated with a greater risk of blood clots in patients' arteries compared with treatment with chemotherapy only. view more (2007-08-08)
Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center. view more (2008-10-01)
Diabetes drug dramatically boosts power of platinum chemotherapy
A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber Cancer Institute report. view more (2007-05-08)
Trial Seeks 'Genetic Fingerprint' for Predicting Drug Effectiveness
University of Cincinnati (UC) physician-scientists believe identifying a genetic "fingerprint" could help predict which specific therapies will be most effective for patients with gastric cancer. view more (2007-10-04)
Anthracyclines improve survival in HER2-positive breast cancer patients
Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors. view more (2007-12-26)
Abdominal chemo boosts survival in ovarian cancer patients
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival-by more than a year-in some women with advanced ovarian cancer. view more (2006-01-05)
Analysis confirms benefits of combining trastuzumab and chemotherapy
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer. view more (2007-07-09)
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. view more (2009-09-24)
Thalidomide treatment proves better than conventional chemotherapy for multiple myeloma
When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment. In a new study, researchers from the University of Bologna, Italy, demonstrate that Thal-Dex (thalidomide used in combination with dexamethasone) is more... view more... (2005-06-21)
True cancer-causing genes revealed by new technique, say Stanford researchers
Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope. view more (2005-06-13)
Standard treatment for lung cancer should be changed, say scientists
Embargoed: 09.00 hrs CET Tuesday 23 September 2003 Copenhagen, Denmark: Patients with non-small cell lung cancer (NSCLC) are more likely to survive if they have chemotherapy after surgery than if they have surgery alone, said a scientist at ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Bengt Bergman, of the... view more... (2003-09-21)
Tablet is better all round for cancer patients
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease. view more (2007-10-09)
Colorectal cancer : A new way of increasing the efficacy of chemotherapy
Inserm and CNRS research scientists and doctors at the Institut Curie have demonstrated the influence of the status - mutated or functional - of the tumour suppressor gene p53 in the response of colorectal cancer to chemotherapy. Tumours in which the p53 gene is mutated respond less well to treatment. However, by adding another agent, researchers... view more... (2004-02-27)
New Herceptin results confirm impressive reduction in risk of cancer returning
New Herceptin results confirm impressive reduction in risk of cancer returning in women with aggressive form of early-stage breast cancer. view more (2005-09-14)
Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-09-25)
Breast cancer follow-ups "no longer guess-work" thanks to new physics research
As the number of breast cancer patients rises, and hospitals struggle to meet the growing cost of healthcare provision, new research by physicists could help divert funds into frontline treatment such as chemotherapy drugs and better imaging technology. Breast cancer is the most common form of cancer in England and Wales and one in nine women... view more... (2004-02-25)
Chemo drugs for treating breast cancer may cause changes in cognitive function
A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what many cancer patients receiving treatment have often complained about - a decline in their memory and other cognitive functions, sometimes characterized as "chemobrain". view more (2006-10-30)
|
|
| Page
4 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
|
